Altamira Therapeutics Ltd.: common_shares_issued
| Value | {"unit": "shares", "value": 87931, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2021-06-30) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/048a0c65-ad04-49cd-959e-1bdb503298a0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-22-076042Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001601936/common-shares-issued/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/048a0c65-ad04-49cd-959e-1bdb503298a0
History
- no predecessors — first report